PHATHOM PHARMACEUTICAL

8.8700

29-November-24 13:45:00

15 minutes delayed

Stocks

-0.1000

-1.11%

Today's range

8.6100 - 9.0129

ISIN

N/A

Source

NASDAQ

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

11 May 2021 08:00:04 By Nasdaq GlobeNewswire
Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

06 May 2021 17:48:26 By Nasdaq GlobeNewswire
Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

29 Apr 2021 16:01:00 By Nasdaq GlobeNewswire
Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

06 Apr 2021 08:00:02 By Nasdaq GlobeNewswire
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress

30 Mar 2021 16:05:01 By Nasdaq GlobeNewswire
Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

19 Jan 2021 08:30:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.